UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The cost of overweight and obesity in Australia

Medical journal of Australia, 2010-03, Vol.192 (5), p.260-264

2010

Volltextzugriff (PDF)

The association between sodium glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population‐based cohort study

Journal of diabetes, 2024-04, Vol.16 (4), p.e13507-n/a

2024

Volltextzugriff (PDF)

Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab)

Medical journal of Australia, 2003-05, Vol.178 (9), p.427-432

2003

Volltextzugriff (PDF)

A systematic review of adherence to diabetes self‐care behaviours: Evidence from low‐ and middle‐income countries

Journal of advanced nursing, 2019-12, Vol.75 (12), p.3374-3389

2019

Volltextzugriff (PDF)

Trends in rates of hospitalisation for infection in people with diabetes and the general population

Diabetic medicine, 2024-08, p.e15421

2024

Volltextzugriff (PDF)

The role of HbA1c in the diagnosis of diabetes mellitus in Australia

Medical journal of Australia, 2012-08, Vol.197 (4), p.220-221

2012

Volltextzugriff (PDF)

Do lifestyle interventions reduce diabetes incidence in people with isolated impaired fasting glucose?

Diabetes, obesity & metabolism, 2021-12, Vol.23 (12), p.2827-2828

2021

Volltextzugriff (PDF)

Projected socioeconomic disparities in the prevalence of obesity among Australian adults

Australian and New Zealand journal of public health, 2012-12, Vol.36 (6), p.557-563

2012

Volltextzugriff (PDF)

Persistent disparities in diabetes medication receipt by socio‐economic disadvantage in Australia

Diabetic medicine, 2022-09, Vol.39 (9), p.e14898-n/a

2022

Volltextzugriff (PDF)

Changes in the incidence of type 2 diabetes in Australia, 2005-2019, overall and by socio-demographic characteristics: a population-based study

Medical journal of Australia, 2024-10

2024

Volltextzugriff (PDF)

A novel approach to accurately measuring the burden of hospitalisations for cardiovascular disease in people with diabetes: A pilot study

Diabetic medicine, 2024-07, Vol.41 (7), p.e15291-n/a

2024

Volltextzugriff (PDF)

The association of glycaemic risk factors and diabetes duration with risk of heart failure in people with type 2 diabetes: A systematic review and meta-analysis

Diabetes, obesity & metabolism, 2024-09

2024

Volltextzugriff (PDF)

Hospital admissions among people with diabetes: A systematic review

Diabetic medicine, 2024-01, Vol.41 (1), p.e15236-n/a

2024

Volltextzugriff (PDF)

Causes of death among Australians with type 1 or type 2 diabetes, 2002–2019

Diabetic medicine, 2024-03, Vol.41 (3), p.e15206-n/a

2024

Volltextzugriff (PDF)

SGLT‐2 Inhibitor Use and Cause‐Specific Hospitalization Rates: An Outcome‐Wide Study to Identify Novel Associations of SGLT‐2 Inhibitors

Clinical pharmacology and therapeutics, 2024-06, Vol.115 (6), p.1304-1315

2024

Volltextzugriff (PDF)

Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study

Clinical endocrinology (Oxford), 2012-07, Vol.77 (1), p.26-35

2012

Volltextzugriff (PDF)

Evaluating the incidence of complications among people with diabetes according to age of onset: Findings from the UK Biobank

Diabetic medicine, 2024-09, Vol.41 (9), p.e15349-n/a

2024

Volltextzugriff (PDF)

Long‐term sustainability of glycaemic achievements with second‐line antidiabetic therapies in patients with type 2 diabetes: A real‐world study

Diabetes, obesity & metabolism, 2018-07, Vol.20 (7), p.1722-1731

2018

Volltextzugriff (PDF)

An Engineered Nanosugar Enables Rapid and Sustained Glucose‐Responsive Insulin Delivery in Diabetic Mice

Advanced materials (Weinheim), 2023-05, Vol.35 (21), p.e2210392-n/a

2023

Volltextzugriff (PDF)

Targeting Diabetes Prevention to More Disadvantaged Groups Improves Cost-Effectiveness: Implications of Inequality in Type 2 Diabetes From Theoretical Interventions

Value in health, 2023-07, Vol.26 (7), p.974-983

2023

Volltextzugriff (PDF)

External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study

Medical journal of Australia, 2019-03, Vol.210 (4), p.161-167

2019

Volltextzugriff (PDF)

The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation

Value in health, 2024-04, Vol.27 (4), p.500-507

2024

Volltextzugriff (PDF)

An Engineered Nanosugar Enables Rapid and Sustained Glucose‐Responsive Insulin Delivery in Diabetic Mice (Adv. Mater. 21/2023)

Advanced materials (Weinheim), 2023-05, Vol.35 (21), p.n/a

2023

Volltextzugriff (PDF)

Excess all‐cause and cause‐specific mortality for people with diabetes and end‐stage kidney disease

Diabetic medicine, 2022-06, Vol.39 (6), p.e14775-n/a

2022

Volltextzugriff (PDF)

Inpatient diabetes care requires adequate support, not just HbA1c screening

Medical journal of Australia, 2019-11, Vol.211 (10), p.452-453

2019

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Aktive Filter

ThemaRisk Factors

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(144)

Publikationsform

Artikel
(149)
Tagungsberichte
(2)

Sprache

Englisch
(151)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The cost of overweight and obesity in Australia

The association between sodium glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population‐based cohort study

Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab)

A systematic review of adherence to diabetes self‐care behaviours: Evidence from low‐ and middle‐income countries

Trends in rates of hospitalisation for infection in people with diabetes and the general population

The role of HbA1c in the diagnosis of diabetes mellitus in Australia

Do lifestyle interventions reduce diabetes incidence in people with isolated impaired fasting glucose?

Projected socioeconomic disparities in the prevalence of obesity among Australian adults

Persistent disparities in diabetes medication receipt by socio‐economic disadvantage in Australia

Changes in the incidence of type 2 diabetes in Australia, 2005-2019, overall and by socio-demographic characteristics: a population-based study

A novel approach to accurately measuring the burden of hospitalisations for cardiovascular disease in people with diabetes: A pilot study

The association of glycaemic risk factors and diabetes duration with risk of heart failure in people with type 2 diabetes: A systematic review and meta-analysis

Hospital admissions among people with diabetes: A systematic review

Causes of death among Australians with type 1 or type 2 diabetes, 2002–2019

SGLT‐2 Inhibitor Use and Cause‐Specific Hospitalization Rates: An Outcome‐Wide Study to Identify Novel Associations of SGLT‐2 Inhibitors

Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study

Evaluating the incidence of complications among people with diabetes according to age of onset: Findings from the UK Biobank

Long‐term sustainability of glycaemic achievements with second‐line antidiabetic therapies in patients with type 2 diabetes: A real‐world study

An Engineered Nanosugar Enables Rapid and Sustained Glucose‐Responsive Insulin Delivery in Diabetic Mice

Targeting Diabetes Prevention to More Disadvantaged Groups Improves Cost-Effectiveness: Implications of Inequality in Type 2 Diabetes From Theoretical Interventions

External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study

The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation

An Engineered Nanosugar Enables Rapid and Sustained Glucose‐Responsive Insulin Delivery in Diabetic Mice (Adv. Mater. 21/2023)

Excess all‐cause and cause‐specific mortality for people with diabetes and end‐stage kidney disease

Inpatient diabetes care requires adequate support, not just HbA1c screening

Aktive Filter

Suchergebnisse filtern